Latest epilepsy Stories
Double-Blind Controlled Clinical Trial Opens Enrollment at the UCLA Semel Institute LOS ANGELES, Jan. 5, 2015 /PRNewswire/ -- NeuroSigma®, Inc.
Multi-disciplinary Tuberous Sclerosis Complex Center to provide greateraccess and quality of care to TSC patients throughout the Midwest. Chicago, IL (PRWEB)
HOUSTON, Dec. 22, 2014 /PRNewswire/ -- Cyberonics, Inc.
The new treatment is known as Epidiolex, and it does not contain the ingredient responsible for creating the high associated with recreational marijuana use.
HOUSTON, Dec. 17, 2014 /PRNewswire/ -- Cyberonics, Inc.
RnRMarketResearch.com adds Seizures Pipeline Review H2 2014 to its store.
New Results Presented at the 68th American Epilepsy Society (AES) Annual Meeting HOUSTON, Dec. 8, 2014 /PRNewswire/ -- Cyberonics, Inc.
Multiple Presentations Highlight Long-Term Safety, Tolerability, and Efficacy Measures, as Adjunctive Therapy for Patients with Refractory Partial-Onset Seizures SEATTLE, Dec.
Findings from Late-Breaking Abstract Demonstrate That Well-Defined Seizure Cluster Terminology is Necessary to Standardize Patient Diagnosis and Allow for Appropriate Treatment Strategies SEATTLE,
- An armed gangster.